Latest Aisling Capital Management LP Stock Portfolio
Aisling Capital Management LP Performance:
2025 Q3: 22.31%YTD: 79.47%2024: -19.02%
Performance for 2025 Q3 is 22.31%, and YTD is 79.47%, and 2024 is -19.02%.
About Aisling Capital Management LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Aisling Capital Management LP reported an equity portfolio of $456.4 Millions as of 30 Sep, 2025.
The top stock holdings of Aisling Capital Management LP are BBIO, VRNA, SNDX. The fund has invested 69.3% of it's portfolio in BRIDGEBIO PHARMA INC. (BBIO) and 14.4% of portfolio in VERONA PHARMA PLC (VRNA).
The fund managers got completely rid off ELEVATION ONCOLOGY INC (ELEV) (ELEV) stocks. Aisling Capital Management LP opened new stock positions in BRIDGEBIO ONCOLOGY THERAPEUTICS (BBOT) and SCHOLAR ROCK HOLDING CORPORATION (SRRK) (SRRK). The fund showed a lot of confidence in some stocks as they added substantially to NUVATION BIO INC. (NUVB) (NUVB) and BRIDGEBIO PHARMA INC. (BBIO) (BBIO).
The top stock holdings of Aisling Capital Management LP are BBIO, VRNA, SNDX. The fund has invested 69.3% of it's portfolio in BRIDGEBIO PHARMA INC. (BBIO) and 14.4% of portfolio in VERONA PHARMA PLC (VRNA).
The fund managers got completely rid off ELEVATION ONCOLOGY INC (ELEV) (ELEV) stocks. Aisling Capital Management LP opened new stock positions in BRIDGEBIO ONCOLOGY THERAPEUTICS (BBOT) and SCHOLAR ROCK HOLDING CORPORATION (SRRK) (SRRK). The fund showed a lot of confidence in some stocks as they added substantially to NUVATION BIO INC. (NUVB) (NUVB) and BRIDGEBIO PHARMA INC. (BBIO) (BBIO).
Aisling Capital Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Aisling Capital Management LP made a return of 22.31% in the last quarter. In trailing 12 months, it's portfolio return was 99.77%.
New Buys
| Ticker | $ Bought |
|---|---|
| bridgebio oncology therapeutics (bbot) | 6,538,360 |
| scholar rock holding corporation (srrk) | 2,868,630 |
New stocks bought by Aisling Capital Management LP
Additions
| Ticker | % Inc. |
|---|---|
| nuvation bio inc. (nuvb) | 16.52 |
| bridgebio pharma inc. (bbio) | 0.35 |
Additions to existing portfolio by Aisling Capital Management LP
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| elevation oncology inc (elev) | -1,040,700 |
Aisling Capital Management LP got rid off the above stocks
Sector Distribution
Aisling Capital Management LP has about 96.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 96.2 |
| Others | 3.8 |
Market Cap. Distribution
Aisling Capital Management LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 83.7 |
| SMALL-CAP | 9 |
| UNALLOCATED | 3.8 |
| MICRO-CAP | 3.5 |
Stocks belong to which Index?
About 80.2% of the stocks held by Aisling Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 80.2 |
| Others | 19.8 |
Aisling Capital Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Aisling Capital Management LP
Aisling Capital Management LP has 14 stocks in it's portfolio. About 99.4% of the portfolio is in top 10 stocks. MRKR proved to be the most loss making stock for the portfolio. BBIO was the most profitable stock for Aisling Capital Management LP last quarter.
Last Reported on: 12 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACRS | aclaris therapeutics inc (acrs) | 0.18 | 434,455 | 825,465 | unchanged | 0.00 | ||
| BBIO | bridgebio pharma inc. (bbio) | 69.30 | 6,089,610 | 316,294,000 | added | 0.35 | ||
| BMEA | biomea fusion inc (bmea) | 0.91 | 2,048,760 | 4,138,490 | unchanged | 0.00 | ||
| CMPS | compass pathways plc (cmps) | 1.50 | 1,198,420 | 6,866,940 | unchanged | 0.00 | ||
| ELEV | elevation oncology inc (elev) | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GLUE | monte rosa therapeutics inc (glue) | 2.39 | 1,472,330 | 10,910,000 | unchanged | 0.00 | ||
| MRKR | marker therapeutics, inc. (mrkr) | 0.06 | 325,370 | 290,425 | unchanged | 0.00 | ||
| NUVB | nuvation bio inc. (nuvb) | 2.40 | 2,960,660 | 10,954,400 | added | 16.52 | ||
| SNDX | syndax pharmaceuticals, inc. (sndx) | 4.44 | 1,316,810 | 20,265,600 | unchanged | 0.00 | ||
| SRRK | scholar rock holding corporation (srrk) | 0.63 | 77,031 | 2,868,630 | new | |||
| VRNA | verona pharma plc (vrna) | 14.39 | 615,352 | 65,664,200 | unchanged | 0.00 | ||
| bicara therapeutics inc. (bcax) | 1.97 | 568,919 | 8,983,230 | unchanged | 0.00 | |||
| bridgebio oncology therapeutics (bbot) | 1.43 | 564,625 | 6,538,360 | new | ||||
| calcimedica, inc. (calc) | 0.35 | 521,114 | 1,602,840 | unchanged | 0.00 | |||
| onkure therapeutics, inc. (okur) | 0.05 | 88,607 | 243,669 | unchanged | 0.00 | |||